Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
October 16 2019
November, November 11-13th 2019: Defymed is happy to announce that we will be present at the 25th an...
October 08 2019
Munich, October 10-13th 2019: Defymed’s CEO, Séverine Sigrist and COO, Richard Bouaoun are glad to p...